Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ after oral administration of ASD formulation at 60 mg eq./kg in rats (6 male rats) (Irwin Study).</p
<p>C<sub>max</sub>: peak plasma concentration; T<sub>max</sub>: time to peak plasma concentration; A...
BackgroundFlubendazole, originally developed to treat infections with intestinal nematodes, has been...
Haematology in dogs in 2-week toxicity study with oral ASD formulation: parameters with flubendazole...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ at Day 14 in satellite rats in 2-we...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ in dogs at Day 14 in 2-week toxicit...
Haematology in rats in 2-week toxicity study with oral ASD formulation: Parameters with flubendazole...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ after 2 days of repeated oral dosin...
Macroscopic findings in rats in 2-week toxicity study with oral ASD formulation on Day 15 (Vehicle, ...
Microscopic findings in male rats in 2-week toxicity study with oral ASD formulation on Day 15 (Vehi...
Microscopic findings in female rats in 2-week toxicity study with oral ASD formulation on Day 15 (Ve...
Organ weights (gram, mean value ± standard deviation) in rats in 2-week toxicity study with oral ASD...
Plasma pharmacokinetic parameters after intravenous and oral administration of ASD formulation of fl...
Plasma concentrations (ng/mL; mean ± standard deviation) of flubendazole, H-FBZ and R-FBZ at 6.5 h a...
Plasma pharmacokinetic parameters of H-FBZ and R-FBZ after oral administration of ASD formulation (m...
<p>Comparative flubendazole (FLBZ) mean (± SD) plasma concentration profiles obtained after administ...
<p>C<sub>max</sub>: peak plasma concentration; T<sub>max</sub>: time to peak plasma concentration; A...
BackgroundFlubendazole, originally developed to treat infections with intestinal nematodes, has been...
Haematology in dogs in 2-week toxicity study with oral ASD formulation: parameters with flubendazole...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ at Day 14 in satellite rats in 2-we...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ in dogs at Day 14 in 2-week toxicit...
Haematology in rats in 2-week toxicity study with oral ASD formulation: Parameters with flubendazole...
Plasma toxicokinetic parameters of flubendazole, H-FBZ and R-FBZ after 2 days of repeated oral dosin...
Macroscopic findings in rats in 2-week toxicity study with oral ASD formulation on Day 15 (Vehicle, ...
Microscopic findings in male rats in 2-week toxicity study with oral ASD formulation on Day 15 (Vehi...
Microscopic findings in female rats in 2-week toxicity study with oral ASD formulation on Day 15 (Ve...
Organ weights (gram, mean value ± standard deviation) in rats in 2-week toxicity study with oral ASD...
Plasma pharmacokinetic parameters after intravenous and oral administration of ASD formulation of fl...
Plasma concentrations (ng/mL; mean ± standard deviation) of flubendazole, H-FBZ and R-FBZ at 6.5 h a...
Plasma pharmacokinetic parameters of H-FBZ and R-FBZ after oral administration of ASD formulation (m...
<p>Comparative flubendazole (FLBZ) mean (± SD) plasma concentration profiles obtained after administ...
<p>C<sub>max</sub>: peak plasma concentration; T<sub>max</sub>: time to peak plasma concentration; A...
BackgroundFlubendazole, originally developed to treat infections with intestinal nematodes, has been...
Haematology in dogs in 2-week toxicity study with oral ASD formulation: parameters with flubendazole...